BIOLASE, INC. Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2024-09-30..
Quick ratio
Overview →Financial period ending 2024-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2024-09-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 30.86M USD | Liabilities, Current |
| Cash and equivalents | 3.44M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 3.53M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 9.87M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2024-09-30 | (m) | $30.86M | $3.44M | (m) | $3.53M | $9.87M | (m) |
| 2024-06-30 | (m) | $31.18M | $5.27M | (m) | $4.84M | $10.90M | (m) |
| 2024-03-31 | (m) | $21.43M | $6.39M | (m) | $5.69M | $11.27M | (m) |
| 2023-12-31 | (m) | $19.66M | $6.57M | (m) | $5.48M | $11.43M | (m) |
| 2023-09-30 | (m) | $19.78M | $7.81M | (m) | $4.39M | $13.82M | (m) |
| 2023-06-30 | (m) | $18.38M | $6.93M | (m) | $5.72M | $13.33M | (m) |
| 2023-03-31 | (m) | $19.00M | $6.53M | (m) | $5.16M | $17.77M | (m) |
| 2022-12-31 | (m) | $17.81M | $4.18M | (m) | $5.84M | $15.88M | (m) |
| 2022-09-30 | (m) | $13.76M | $9.96M | (m) | $4.85M | $16.43M | (m) |
| 2022-06-30 | (m) | $13.95M | $19.55M | (m) | $6.08M | $16.57M | (m) |
| 2022-03-31 | (m) | $13.11M | $21.61M | (m) | $5.18M | $14.61M | (m) |
| 2021-12-31 | (m) | $13.84M | $29.97M | (m) | $4.24M | $12.93M | (m) |
| 2021-09-30 | (m) | $13.46M | $33.38M | (m) | $3.64M | $14.06M | (m) |
| 2021-06-30 | (m) | $12.72M | $37.08M | (m) | $3.82M | $12.71M | (m) |
| 2021-03-31 | (m) | $11.27M | $40.84M | (m) | $3.27M | $11.88M | (m) |
| 2020-12-31 | (m) | $11.22M | $17.56M | (m) | $3.06M | $11.16M | (m) |
| 2020-09-30 | (m) | $21.43M | $18.85M | (m) | $3.39M | $12.59M | (m) |
| 2020-06-30 | (m) | $21.09M | $5.44M | (m) | $4.12M | $11.93M | (m) |
| 2020-03-31 | (m) | $23.68M | $1.51M | (m) | $4.75M | $12.19M | (m) |
| 2019-12-31 | (m) | $25.78M | $5.79M | (m) | $8.76M | $10.99M | (m) |
| 2019-09-30 | (m) | $14.07M | $2.09M | (m) | $8.47M | $11.54M | (m) |
| 2019-06-30 | (m) | $13.29M | $3.72M | (m) | $9.74M | $12.33M | (m) |
| 2019-03-31 | (m) | $15.12M | $2.96M | (m) | $11.74M | $12.02M | (m) |
| 2018-12-31 | (m) | $15.97M | $8.04M | (m) | $11.11M | $12.25M | (m) |
| 2018-09-30 | (m) | $17.25M | $2.24M | (m) | $11.40M | $13.42M | (m) |
| 2018-06-30 | (m) | $14.73M | $2.90M | (m) | $10.40M | $14.01M | (m) |
| 2018-03-31 | (m) | $13.13M | $8.48M | (m) | $9.74M | $13.40M | (m) |
| 2017-12-31 | (m) | $13.37M | $11.64M | (m) | $10.12M | $12.30M | (m) |
| 2017-09-30 | (m) | $15.03M | $4.45M | (m) | $9.71M | $14.10M | (m) |
| 2017-06-30 | (m) | $15.61M | $7.92M | (m) | $9.80M | $15.19M | (m) |
| 2017-03-31 | (m) | $17.11M | $3.58M | (m) | $9.22M | $14.69M | (m) |
| 2016-12-31 | (m) | $18.01M | $8.92M | (m) | $9.78M | $13.52M | (m) |
| 2016-09-30 | (m) | $16.45M | (m) | (m) | $9.94M | $13.54M | (m) |
| 2016-06-30 | (m) | $14.95M | (m) | (m) | $11.04M | $11.26M | (m) |
| 2016-03-31 | (m) | $14.55M | (m) | (m) | $10.11M | $12.57M | (m) |
| 2015-12-31 | (m) | $15.11M | (m) | (m) | $8.95M | $12.57M | (m) |
| 2015-09-30 | (m) | $18.30M | (m) | (m) | $9.24M | $14.12M | (m) |
| 2015-06-30 | (m) | $17.91M | (m) | (m) | $9.78M | $13.68M | (m) |
| 2015-03-31 | (m) | $15.76M | (m) | (m) | $9.81M | $13.17M | (m) |
| 2014-12-31 | (m) | $16.15M | (m) | (m) | $9.00M | $12.51M | (m) |
| 2014-09-30 | (m) | $17.77M | (m) | (m) | $9.26M | $11.80M | (m) |
| 2014-06-30 | (m) | $22.60M | (m) | (m) | $6.60M | $11.85M | (m) |
| 2014-03-31 | (m) | $19.02M | (m) | (m) | $8.56M | $11.89M | (m) |
| 2013-12-31 | (m) | $21.94M | (m) | (m) | $11.13M | $11.38M | (m) |
| 2013-09-30 | (m) | $22.72M | (m) | (m) | $10.80M | $11.74M | (m) |
| 2013-06-30 | (m) | $23.67M | (m) | (m) | $11.48M | $12.56M | (m) |
| 2013-03-31 | (m) | $20.26M | (m) | (m) | $10.64M | $11.92M | (m) |
| 2012-12-31 | (m) | $19.38M | (m) | (m) | $11.68M | $11.14M | (m) |
| 2012-09-30 | (m) | $17.66M | (m) | (m) | $10.31M | $11.20M | (m) |
| 2012-06-30 | (m) | $16.83M | (m) | (m) | $9.58M | $10.70M | (m) |
| 2012-03-31 | (m) | $15.22M | (m) | (m) | $8.98M | $10.34M | (m) |
| 2011-12-31 | (m) | $16.28M | (m) | (m) | $8.90M | $11.31M | (m) |
| 2011-09-30 | (m) | $13.70M | (m) | (m) | $8.07M | $9.82M | (m) |
| 2011-06-30 | (m) | $13.57M | (m) | (m) | $6.40M | $8.03M | (m) |
| 2011-03-31 | (m) | (m) | $1.63M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $19.66M | (m) | (m) | $3.33M | $6.99M | (m) |
| 2010-09-30 | (m) | (m) | $2.23M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $2.90M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $2.98M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $11.23M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.